Neurotez, Inc., Announced That It Has Contracted with Paragon Bioservices for the Manufacturing of a Leptin Product for the Treatment of Alzheimer's Disease and Other Cognitive Disorders

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Neurotez, Inc., announced that it has developed two (2) Leptin products for the treatment of Alzheimer’s disease and other cognitive disorders and has contracted with Paragon Bioservices, Inc. for process optimization and GMP manufacturing of one of these products.

Back to news